Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 14 results found. Search for [ Indian Immunologicals Ltd ]

Results 1 to 14 of 14
BusinessToday.In
June 15, 2021
The delay in ramping up production is because of slower-than-expected pace of technology transfer to PSEs selected by government to produce the vaccine


PTI
June 1, 2021
Cipla has said such an assurance will help make this significant financial commitment of more than $1 billion (over Rs 7,250 crore) advance to Moderna for its booster vaccine in India


PTI
May 30, 2021
In a letter to all states and UTs, Additional Secretary to Health ministry Manohar Agnani said it has come to the notice of the ministry that some private hospitals are giving package for COVID vaccination in collaboration with some hotels


BusinessToday.In
May 29, 2021
The Delhi government has floated the global tender to scale up the COVID-19 vaccination drive in the national capital


PTI
May 29, 2021
IIL's Managing Director K Anand Kumar said the firm is expected to produce the drug substance initially for 2-3 million doses per month


PTI
May 21, 2021
The Centre will also take up with Moderna, Johnson and Johnson and other vaccine makers the issue of granting voluntary licence to third-party manufacturers in India on transfer of technology basis


BusinessToday.In
May 15, 2021
Among the public sector companies, Mumbai-based Haffkine Biopharmaceutical Corporation Ltd has been provided a grant of Rs 65 crore for manufacturing Covaxin.


BusinessToday.In
April 16, 2021
The Centre is providing financial support as grant to vaccine manufacturing facilities to enhance their production capacities.


PB Jayakumar
November 25, 2020
The new facility, spread across 2,000 square meters with Bio Safety Level (BSL) 3 suite, will be specially designed as a multiproduct facility for viral vaccines in the pipeline that includes dengue, Zika and varicella


BusinessToday.In
July 20, 2020
Hyderabad-based Bharat Bharat Biotech India (BBIL) in collaboration with ICMR's National Institute of Virology (NIV) has developed India's first indigenous COVID-19 vaccine candidate Covaxin


BusinessToday.In
May 9, 2020
Coronavirus vaccine: World leaders and organisations, except the United States, have already pledged $8 billion to research, manufacture and distribute a possible vaccine and treatments for COVID-19 apart from the individual efforts taken by the countries and its pharmaceutical firms


BusinessToday.In
New Delhi, May 6, 2020
United States has been worst affected nation with 72,275 deaths, followed by the UK, Italy and Spain; as spread of coronavirus shows no sign of slowing down, researchers and various governments are doubling efforts to develop a vaccine


PB Jayakumar
May 6, 2020
Regulatory agencies have fast-tracked the vaccine development, which normally takes 7-10 years to reach the market


Manu Kaushik
May 15, 2012
A new breed of skill development companies works closely with industry to not only provide training, but also guarantee jobs.


PAGES 1 OF 1